secwatch.observer — SEC 8-K summary
======================================

Issuer:     Core Laboratories Inc. /DE/ (CLB)
CIK:        0001958086
Form:       8-K
Filed at:   2024-01-31T23:59:59+00:00
Accession:  0000950170-24-009489
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Core Lab Q4 revenue $128.2M (+2% seq); EPS ex-items $0.19 (-14% seq); FY EPS +40%
--------------------------------------------------------------------------------

- Q4 revenue $128.2M (+2% sequentially); GAAP EPS $0.14, ex-items EPS $0.19 (down 14% seq).
- Q4 operating income ex-items $15.0M (12% margins); free cash flow $16.7M; debt cut $15M (8%).
- Full year revenue $510.0M (+4% YoY); operating income ex-items $61.2M (+36%); EPS ex-items $0.80 (+40%).
- Quarterly cash dividend $0.01/share, record Feb 12, payable Mar 4, 2024.
- Effective tax rate impacted by non-cash deferred tax adjustments from U.S. domestication.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958086/000095017024009489/0000950170-24-009489-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958086/000095017024009489/clb-20240131.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-009489

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer